-
. While in the Hummon research group, this candidate will embark on a program of independent research with the primary goal to develop mass spectrometry methods in proteomics, metabolomics, and imaging
-
, immunology, molecular biology, proteomics, animal modeling and mouse genetics, translational medicine, and/or the use of human tumor models of cancers. Develops, adopts and implements new laboratory methods
-
cytometry, DNA replication track analysis, Western blot analysis, chromatin immunoprecipitation (ChIP), proteomics, next-generation sequencing and analysis, genome and epigenome editing, small-molecule
-
, immunology, molecular biology, proteomics, animal modeling and mouse genetics, translational medicine, and/or the use of human tumor models of solid tumors (e.g. breast cancer, colon cancer, neuroblastoma
-
, Medicinal Chemistry, Microscopy, Nutrient and Phytochemical Analytics, Pharmacoanalytical, Proteomics, and Small Animal Imaging, Solid Tumor Translational Sciences, Target Validation, and Veterinary Clinical